Value of nocturnal pulse oxygen saturation in predicting patients with obstructive sleep apnea hypopnea syndrome complicating with type 2 diabetes
-
摘要:目的 探讨夜间脉搏血氧饱和度(SpO2)水平对阻塞性睡眠呼吸暂停低通气综合征(OSAHS)伴2型糖尿病患者的预测价值。方法 回顾性分析153例OSAHS患者的临床资料, 根据是否患有2型糖尿病分为OSAHS伴2型糖尿病组77例和单纯OSAHS组76例。比较2组人口统计学资料、病史资料和SpO2水平,并分析夜间SpO2对OSAHS患者伴2型糖尿病的预测效能。结果 与单纯OSAHS组比较, OSAHS伴2型糖尿病组患者年龄较大,体质量指数(BMI)、呼吸暂停低通气指数(AHI)和氧减指数(ODI)较高,高脂血症患病率和有糖尿病家族史者占比较高,平均脉搏血氧饱和度(MSpO2)和最低脉搏血氧饱和度(LSpO2)水平较低,差异有统计学意义(P<0.05)。二元Logistic回归分析发现,年龄小(OR=0.247, 95%CI为0.110~0.553, P=0.001)、BMI低(OR=0.366, 95%CI为0.152~0.881, P=0.025)是OSAHS患者伴2型糖尿病的保护因素,高脂血症(OR=2.337, 95%CI为1.068~5.113, P=0.034)、LSpO2降低(OR=3.511, 95%CI为1.132~10.891, P=0.030)是OSAHS患者伴2型糖尿病的危险因素。LSpO2预测OSAHS患者伴2型糖尿病的最佳截断值为76.50%(敏感度54.5%, 特异度75.0%)。结论 夜间LSpO2与OSAHS患者2型糖尿病的发生有关, LSpO2水平降低可能对OSAHS患者伴发2型糖尿病具有一定预测价值。
-
关键词:
- 阻塞性睡眠呼吸暂停低通气综合征 /
- 2型糖尿病 /
- 血氧饱和度 /
- 预测价值
Abstract:Objective To investigate the predictive value of nocturnal pulse oxygen saturation(SpO2) in patients with obstructive sleep apnea hypopnea syndrome (OSAHS) complicating with type 2 diabetes.Methods The clinical data of 153 patients with OSAHS were retrospectively analyzed, and they were divided into single OSAHS group (76 cases) and OSAHS with type 2 diabetes group (77 cases) according to whether they had type 2 diabetes or not. The demographic data, the medical history data and SpO2 level between the two groups were compared, and the predictive efficacy of nocturnal SpO2 for OSAHS patients with type 2diabetes was analyzed.Results Compared with the single OSAHS group, the age of the OSAHS with type 2 diabetes group was older, body mass index (BMI), apnea hypopnea index (AHI) and oxygen deoxygenation index (ODI) were higher, prevalence of hyperlipidemia and proportion of family history of diabetes were higher, the mean oxygen saturation (MSpO2) and lowest oxygen saturation (LSpO2) levels were lower (P < 0.05). Logistic regression analysis showed that younger age(OR=0.247, 95%CI, 0.110 to 0.553, P=0.001) and lower BMI(OR=0.366, 95%CI, 0.152 to 0.881, P=0.025) were protective factors forOSAHS patients complicating with type 2 diabetes, while hyperlipidemia (OR=2.337, 95%CI, 1.068 to 5.113, P=0.034)and decreased LSpO2(OR=3.511, 95%CI, 1.132 to 10.891, P=0.030) were risk factors for OSAHS patients with type 2 diabetes. The optimal cut-off value of LSpO2 in predicting OSAHS patients with type 2 diabetes mellitus was 76.50% (with sensitivity of 54.5%, specificity of 75.0%).Conclusion LSpO2 is associated with the occurrence of type 2 diabetes in patients with OSAHS, and the reduced LSpO2 level may have a certain predictive value for patients with OSAHS complicating with type 2 diabetes. -
-
表 1 2组患者一般资料与睡眠监测指标水平比较(x±s) [n(%)]
指标 OSAHS伴2型糖尿病组(n=77) 单纯OSAHS组(n=76) t/χ2 P 年龄/岁 59.19±12.17 54.42±13.14 -2.332 0.021 性别 男 51(66.23) 56(73.68) 1.010 0.315 女 26(33.77) 20(26.32) BMI/(kg/m2) 27.65±4.20 25.52±2.85 -3.680 <0.001 吸烟史 26(33.77) 22(28.95) 0.413 0.521 饮酒史 24(31.17) 22(28.95) 0.09 0.764 高血压病 60(77.92) 55(72.37) 0.632 0.427 高脂血症 46(59.74) 28(36.84) 8.03 0.005 动脉粥样硬化性心血管疾病 31(40.26) 36(47.37) 0.785 0.376 糖尿病家族史 19(24.68) 9(11.84) 4.213 0.040 AHI/(次/h) 31.98±22.22 25.45±17.87 -2.004 0.047 ODI/(次/h) 29.28±23.49 22.46±16.92 -2.063 0.041 MSpO2/% 92.64±3.24 94.50±3.37 3.482 0.001 LSpO2/% 70.61±12.05 78.04±8.97 4.327 <0.001 OSAHS: 阻塞性睡眠呼吸暂停低通气综合征; BMI: 体质量指数; AHI: 呼吸暂停低通气指数; ODI: 氧减指数; MSpO2: 平均脉搏血氧饱和度; LSpO2: 最低脉搏血氧饱和度。 表 2 OSAHS患者伴2型糖尿病影响因素的二元Logistic回归分析
因素 B SE Walds P OR 95%CI 年龄/岁 -1.399 0.412 11.554 0.001 0.247 0.110~0.553 BMI/(kg/m2) -1.004 0.448 5.033 0.025 0.366 0.152~0.881 高脂血症 0.849 0.399 4.517 0.034 2.337 1.068~5.113 糖尿病家族史 0.979 0.512 3.654 0.056 2.661 0.976~7.258 AHI/(次/h) 0.259 0.667 0.151 0.697 1.296 0.351~4.787 ODI/(次/h) 0.469 0.732 0.41 0.522 1.598 0.380~6.712 MSpO2/% 0.762 0.457 2.772 0.096 2.142 0.874~5.251 LSpO2/% 1.256 0.578 4.728 0.030 3.511 1.132~10.891 OSAHS: 阻塞性睡眠呼吸暂停低通气综合征; AHI: 呼吸暂停低通气指数; ODI: 氧减指数; BMI: 体质量指数; MSpO2: 平均脉搏血氧饱和度; LSpO2: 最低脉搏血氧饱和度。 -
[1] RONNI B, DANIELA G, MANFRED I, et al. The effect of continuous positive airway pressure therapy on obstructive sleep apnea-related hypertension[J]. Int J Mol Sci, 2021, 22(5): 2300. doi: 10.3390/ijms22052300
[2] OTA H, FUJITA Y, YAMAUCHI M, et al. Relationship between intermittent hypoxia and type 2 diabetes in sleep apnea syndrome[J]. Int J Mol Sci, 2019, 20(19): 4756. doi: 10.3390/ijms20194756
[3] SHEN H, ZHAO J R, LIU Y, et al. Interactions between and shared molecular mechanisms of diabetic peripheral neuropathy and obstructive sleep apnea in type 2 diabetes patients[J]. J Diabetes Res, 2018, 2018: 3458615.
[4] JORDAN A S, MCSHARRY D G, MALHOTRA A. Adult obstructive sleep apnoea[J]. Lancet, 2014, 383(9918): 736-747. doi: 10.1016/S0140-6736(13)60734-5
[5] 中华医学会呼吸病学分会睡眠呼吸疾病学组. 阻塞性睡眠呼吸暂停低通气综合征诊治指南(草案)[J]. 中华内科杂志, 2003, 42(8): 594-597. doi: 10.3760/j.issn:0578-1426.2003.08.033 [6] 中华医学会糖尿病学分会. 中国2型糖尿病防治指南(2013年版)[J]. 中国糖尿病杂志, 2014, 22(8): 2-42. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGTL201408030.htm [7] AGATA G, JEDRZEJ C, MARCIN S, et al. Nocturnal oxygen saturation parameters as independent risk factors for type 2 diabetes mellitus among obstructive sleep apnea patients[J]. J Clin Med, 2021, 10(17): 3770. doi: 10.3390/jcm10173770
[8] ANTONINO M, GIANNICOLA I, SALVATORE C, et al. Oxidative stress and inflammation biomarker expression in obstructive sleep apnea patients[J]. J Clin Med, 2021, 10(2): 277. doi: 10.3390/jcm10020277
[9] 胡碧, 王茂筠, 雷飞, 等. 夜间动态血氧饱和度监测结合临床评分对阻塞性睡眠呼吸暂停低通气综合征患者的初筛价值[J]. 中国呼吸与危重监护杂志, 2017, 16(3): 245-249. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGHW201703008.htm [10] BLASER H, DOSTERT C, MAK T W, et al. TNF and ROS crosstalk in inflammation[J]. Trends Cell Biol, 2016, 26(4): 249-261. doi: 10.1016/j.tcb.2015.12.002
[11] BLACK P H. The inflammatory response is an integral part of the stress response: implications for atherosclerosis, insulin resistance, type Ⅱ diabetes and metabolic syndrome X[J]. Brain Behav Immun, 2003, 17(5): 350-364. doi: 10.1016/S0889-1591(03)00048-5
[12] MALKOV M I, TEIK L C, TAYLOR C T. Regulation of the hypoxia-inducible factor (HIF) by pro-inflammatory cytokines[J]. Cells, 2021, 10(9): 2340. doi: 10.3390/cells10092340
[13] AGATA G, FRANCISZEK K F, BARTOSZ S, et al. HIF-1α as a mediator of insulin resistance, T2DM, and its complications: potential links with obstructive sleep apnea[J]. Front Physiol, 2020, 11: 1035. doi: 10.3389/fphys.2020.01035
[14] OK S S, KEN H, NARLA R R, et al. Metabolic consequences of obstructive sleep apnea especially pertaining to diabetes mellitus and insulin sensitivity[J]. Diabetes Metab J, 2019, 43(2): 144-155. doi: 10.4093/dmj.2018.0256
[15] RYAN S. Adipose tissue inflammation by intermittent hypoxia: mechanistic link between obstructive sleep apnoea and metabolic dysfunction[J]. J Physiol, 2017, 595(8): 2423-2430. doi: 10.1113/JP273312
[16] WANG N, KHAN S A, PRABHAKAR N R, et al. Impairment of pancreatic β-cell function by chronic intermittent hypoxia[J]. Exp Physiol, 2013, 98(9): 1376-1385. doi: 10.1113/expphysiol.2013.072454
[17] POLAK J, SHIMODA L A, DRAGER L F, et al. Intermittent hypoxia impairs glucose homeostasis in C57BL6/J mice: partial improvement with cessation of the exposure[J]. Sleep, 2013, 36(10): 1483-1490. doi: 10.5665/sleep.3040
[18] MURAKI I, TANIGAWA T, YAMAGISHI K, et al. Nocturnal intermittent hypoxia and the development of type 2 diabetes: the Circulatory Risk in Communities Study (CIRCS)[J]. Diabetologia, 2010, 53(3): 481-488. doi: 10.1007/s00125-009-1616-0
[19] 于悦, 谭慧文, 刘奕姝, 等. 阻塞性睡眠呼吸暂停低通气综合征病情严重程度的影响因素及代谢相关激素与临床相关指标的关系研究[J]. 中国全科医学, 2021, 24(8): 947-953. https://www.cnki.com.cn/Article/CJFDTOTAL-QKYX202108025.htm [20] 胡碧, 王茂筠, 王怡唯, 等. 夜间动态血氧饱和度监测对代谢综合征合并阻塞性睡眠呼吸暂停低通气综合征患者的意义研究[J]. 中国全科医学, 2017, 20(11): 1287-1293. https://www.cnki.com.cn/Article/CJFDTOTAL-QKYX201711005.htm [21] APPLETON S L, VAKULIN A, WITTERT G A, et al. The association of obstructive sleep apnea (OSA) and nocturnal hypoxemia with the development of abnormal HbA1c in a population cohort of men without diabetes[J]. Diabetes Res Clin Pract, 2016, 114: 151-159. doi: 10.1016/j.diabres.2015.12.007
[22] HUI P L, ZHAO L J, XIE Y P, et al. Nocturnal hypoxemia causes hyperglycemia in patients with obstructive sleep apnea and type 2 diabetes mellitus[J]. Am J Med Sci, 2016, 351(2): 160-168. doi: 10.1016/j.amjms.2015.12.002